Back to today’s briefing

Story perspectives

Trump and Walmart Team Up to Cut Drug Prices

6/29/2025

42 8

Summary

Story summary

In June 2025, officials from the Trump administration and Walmart joined forces to tackle soaring U.S. prescription drug prices through a groundbreaking direct-to-patient sales model. This ambitious plan, leveraging the Most-Favored-Nation pricing policy, could shake up the $1.4 trillion pharmaceutical industry, though it grapples with regulatory hurdles and pushback from drug manufacturers.

1 of 1

Story summary

In June 2025, officials from the Trump administration and Walmart joined forces to tackle soaring U.S. prescription drug prices through a groundbreaking direct-to-patient sales model. This ambitious plan, leveraging the Most-Favored-Nation pricing policy, could shake up the $1.4 trillion pharmaceutical industry, though it grapples with regulatory hurdles and pushback from drug manufacturers.